生命科学资讯

Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess

After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate

Accent axes a cancer study; Werewolf considers its options

Alkermes CEO Richard Pops to retire after 35-year tenure

States sue Kennedy over US childhood vaccine overhaul

15 states sue HHS over changes to childhood vaccine schedule

Novo Nordisk teams with Langer-founded biotech for oral obesity drugs

Covant Therapeutics patents FcRn antagonists

Blossomhill Therapeutics reports new EGFR inhibitors

PARG inhibitors disclosed in Avelos Therapeutics patent

Shanghai Meiyue Biotech patents divulge c-KIT inhibitors

Waverley Pharma synthesizes PARP-1 inhibitors

With Vivtex deal, Novo gains a chance at better oral obesity drugs

China’s biopharma advance draws financial investment

Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy

GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug

BreezeBio banks $60M to make more precise genetic medicines

GSK to buy pulmonary hypertension biotech 35Pharma for $950M

Illumina Genome Push Raises Questions On Growth, Adoption And Valuation - simplywall.st

Cytiva expands Fast Trak™ process development and validation services facility in India - BioSpectrum India